Asymchem
Asymchen combines molecular biology technology
Asymchen combines molecular biology technology, fermentation technology and process development technology to provide customers with carbapenems, cGMP APIs and other products used in anti-viral, anti-cancer, cardiovascular and cerebrovascular diseases, diabetes and other major diseases, and cooperates with Novartis, Bristol-Myers Squibb, AstraZeneca and GlaxoSmithKline.
Cro plate fell, and Wuxi apptec fell nearly 10%
China's First Modified New Drug of Docetaxel Successfully Went to the US
Feb 19, 2025 10:41 AM